ArticleClinical pharmacology in drug development2022

Clinical Formulation Bridging of Gefapixant, a P2X3-Receptor Antagonist, for the Treatment of Chronic Cough.

Pranav Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.